Literature DB >> 1984408

Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases.

K Abe1, M Yoshida, T Usui, S Horinouchi, T Beppu.   

Abstract

The effect of staurosporine, a potent microbial inhibitor of protein kinases, on the cell cycle of cultured fibroblast cells was investigated. A low concentration of staurosporine (1-10 ng/ml) blocked the cell cycle of rat 3Y1 fibroblasts at the early G1 phase within 2 h after serum stimulation. On the other hand, a higher concentration of the drug (100 ng/ml) caused the specific G2 block. Both of these blocks were reversible. After release from the G2 block, highly synchronous transition to M phase was observed and both nuclear and cell divisions were completed within 180 min. This reversible G2 block showed a clear contrast to those by the other G2 arresters, trichostatin A and leptomycin B, which formed proliferative tetraploid cells after release by entering the cells into a new S phase without passage through M phase. The presence of trichostatin A or leptomycin B did not interfere with this synchronous progression through G2/M phases, suggesting that the arrest point of staurosporine was present in late G2 phase following those of trichostatin A and leptomycin B.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984408     DOI: 10.1016/0014-4827(91)90166-r

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  21 in total

1.  Establishment of a tetraploid Meth-A cell line through polyploidization by demecolcine but not by staurosporine, K-252A and paclitaxel.

Authors:  K Fujikawa-Yamamoto; S Wang; H Yamagishi; C Ohdoi; H Murano; T Ikeda
Journal:  Cell Prolif       Date:  2001-08       Impact factor: 6.831

Review 2.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

3.  G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637.

Authors:  J B Schnier; K Nishi; D W Goodrich; E M Bradbury
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.

Authors:  M D Jacobsen; M Weil; M C Raff
Journal:  J Cell Biol       Date:  1996-06       Impact factor: 10.539

5.  Staurosporine-induced growth inhibition of glioma cells is accompanied by altered expression of cyclins, CDKs and CDK inhibitors.

Authors:  Mugdha N Harmalkar; Neelam V Shirsat
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

6.  A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells.

Authors:  M Nagai; H Yamada; S Nakada; K Ochi; T Nemoto; S Takahara; S Hoshina; J Horiguchi-Yamada
Journal:  Mol Cell Biochem       Date:  1995-03-23       Impact factor: 3.396

7.  Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells.

Authors:  D M Gadbois; H A Crissman; R A Tobey; E M Bradbury
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

8.  Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle.

Authors:  H A Crissman; D M Gadbois; R A Tobey; E M Bradbury
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Characterization of a staurosporine- and temperature-sensitive mutant, stt1, of Saccharomyces cerevisiae: STT1 is allelic to PKC1.

Authors:  S Yoshida; E Ikeda; I Uno; H Mitsuzawa
Journal:  Mol Gen Genet       Date:  1992-02

10.  Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.

Authors:  S Akinaga; K Nomura; K Gomi; M Okabe
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.